引用本文:郭永传,张益宏,马守战,贾思明.应用hybrid术式治疗多节段脊髓型颈椎病的疗效观察[J].中国临床新医学,2017,10(1):25-27.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1647次   下载 1269 本文二维码信息
码上扫一扫!
分享到: 微信 更多
应用hybrid术式治疗多节段脊髓型颈椎病的疗效观察
郭永传,张益宏,马守战,贾思明
475000 河南,开封市中心医院骨科五病区
摘要:
[摘要] 目的 探讨hybrid术式治疗多节段脊髓型颈椎病的疗效。方法 2011-04~2013-05对该科收治的多节段颈椎病患者37例行颈椎前路融合与非融合相结合的hybrid术式(A组),记录手术前后JOA、NDI评分、颈椎总活动度及手术节段的邻近节段的活动度,术后随访2.5年,通过与单纯融合组(B组)比较,分析其治疗效果。结果 术后2.5年A、B两组患者JOA评分及改良率、NDI评分、轴性症状的构成比、颈椎总活动度、手术前后邻近节段活动度差值相比,差异有统计学意义(P<0.05)。结论 hybrid术式能够保留一定节段的活动度,避免邻近节段的过度代偿导致的应力负荷增加,是治疗多个节段脊髓型颈椎病的有效方法。
关键词:  hybrid术式  融合-非融合技术  脊髓型颈椎病  疗效观察  随访
DOI:10.3969/j.issn.1674-3806.2017.01.08
分类号:R 68
基金项目:
Efficacy of hybrid surgical treatment for multilevel cervical myelopathy
GUO Yong-chuan,ZHANG Yi-hong,MA Shou-zhan,et al.
The Fifth Department of Orthopedics, the Central Hospital of Kaifeng City, Henan 475000,China
Abstract:
[Abstract] Objective To analyze the effect of hybrid surgery on multilevel cervical myelopathy.Methods Thirty-seven cases with multilevel cervical spondylosis in our department from April 2011 to May 2013 were performed anterior cervical fusion combined with non-fusion hybrid procedure(group A), and simple anterior cervical fusion group(group B). The scores of pre-and-postoperative JOA and NDI, ROM of adjacent segments of the cervical spine and the total ROM of the proposed operation segments were compared between the two groups after a follow-up of 2.5 years.Results After the follow-up of 2.5 years, there were significant differences in JOA scores and its improvement rate, NDI scores, the total activity of the cervical spine, axial symptoms, and pre-and-postoperative adjacent segmental ROM and total ROM between group A and group B(P<0.05).Conclusion Hybrid surgery retains a certain degree of activity segments, adjacent segments to avoid the stress load increases due to excessive compensation, which is an effective method for treating multiple segments cervical spinal cord disease.
Key words:  Hybrid  Fusion and non-fusion technology  Cervical myelopathy  Efficacy  Follow-up